AMAG Pharmaceuticals: 2Q Earnings Snapshot
WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Wednesday reported a loss of $120.8 million in its second quarter.
On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of $3.57. Losses, adjusted for asset impairment costs, came to $1.28 per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 66 cents per share.
The specialty drugmaker posted revenue of $78.1 million in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $92.1 million.
AMAG Pharmaceuticals shares have decreased 36% since the beginning of the year. The stock has dropped 60% in the last 12 months.